跳至主要内容
临床试验/NCT00586482
NCT00586482已完成4 期

The Role of Nicotine Lozenges in Reducing Preoperative Exposure to Cigarette Smoke

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 46 人开始时间: 2006年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
Mayo Clinic
入组人数
46
试验地点
1
主要终点
Exhaled Carbon Monoxide Concentration

研究概览

简要总结

The goal of this pilot study is to determine the feasibility and potential effect size of nicotine lozenges as an adjunct to maintain brief preoperative abstinence, defined as not smoking the day of surgery.

详细描述

Nicotine replacement therapy (NRT) helps patients maintain prolonged abstinence; whether it might also be efficacious in helping smokers maintain preoperative "fasting" from smoking is not known. A goal of this study is to determine how to best decrease smokers' exposure to cigarette smoke immediately before surgery. The specific aim of this study is to test the hypothesis that NRT in the form of nicotine lozenges will decrease the exposure to cigarette smoke prior to surgery. This is a randomized, double blinded, placebo controlled clinical trial examining the efficacy of the nicotine lozenge in increasing preoperative abstinence from cigarettes in patients scheduled for elective surgery. Current smokers scheduled for any of a wide variety of elective surgical procedures will be recruited in the Mayo Clinic Rochester Preoperative Evaluation Center. and will receive a brief practice-based intervention encouraging preoperative abstinence for at least 12 hours before admission to the surgical facility. They will be randomized to receive either active or placebo lozenge.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Current cigarette smoker, defined as >100 cigarettes lifetime consumption and self report of smoking every day
  • Scheduled for elective non-cardiac surgery

排除标准

  • An inability to understand consent procedures
  • History of an allergic reaction to nicotine replacement therapy
  • History of sustained ventricular tachycardia
  • Untreated hyperthyroidism or pheochromocytoma
  • Currently utilizing pharmacologic agents specifically to treat nicotine dependence, including nicotine replacement therapy and bupropion (for a stop-smoking indication)
  • Active (within the past 12 months) non-nicotine drug dependence
  • Females who are pregnant or lactating
  • Patients with phenylketonuria, because the lozenges contain aspartame, which is metabolized to phenylalanine.
  • Lack of access to a telephone, as one follow-up will be performed using this means.

研究组 & 干预措施

Nicotine lozenge

Active Comparator

Nicotine lozenges, 2 or 4 mg, taken without restriction by mouth from 7 pm the evening before surgery until surgical admission the next day. Dosed according to time to first morning cigarette; if within 30 minutes of awakening, 4 mg lozenge used. If first cigarette smoked greater than 30 minutes of awakening, 2 mg lozenge used.

Subjects also received an abstinence advisement: a brief (approximately 2 minute) behavioral intervention advising abstinence from smoking after 7 pm the night before surgery, the potential benefits of abstinence and to use a lozenge at usual smoking times.

干预措施: Nicotine Lozenge (Drug)

Nicotine lozenge

Active Comparator

Nicotine lozenges, 2 or 4 mg, taken without restriction by mouth from 7 pm the evening before surgery until surgical admission the next day. Dosed according to time to first morning cigarette; if within 30 minutes of awakening, 4 mg lozenge used. If first cigarette smoked greater than 30 minutes of awakening, 2 mg lozenge used.

Subjects also received an abstinence advisement: a brief (approximately 2 minute) behavioral intervention advising abstinence from smoking after 7 pm the night before surgery, the potential benefits of abstinence and to use a lozenge at usual smoking times.

干预措施: Abstinence Advisement (Behavioral)

Placebo lozenge

Placebo Comparator

Placebo lozenges, matching in appearance the 2 and 4 mg active nicotine lozenges, taken by mouth without restriction from 7 pm the night before surgery to the time of surgical admission the next day.

Subjects also received an abstinence advisement: a brief (approximately 2 minute) behavioral intervention advising abstinence from smoking after 7 pm the night before surgery, the potential benefits of abstinence and to use a lozenge at usual smoking times.

干预措施: Placebo Lozenge (Drug)

Placebo lozenge

Placebo Comparator

Placebo lozenges, matching in appearance the 2 and 4 mg active nicotine lozenges, taken by mouth without restriction from 7 pm the night before surgery to the time of surgical admission the next day.

Subjects also received an abstinence advisement: a brief (approximately 2 minute) behavioral intervention advising abstinence from smoking after 7 pm the night before surgery, the potential benefits of abstinence and to use a lozenge at usual smoking times.

干预措施: Abstinence Advisement (Behavioral)

结局指标

主要结局

Exhaled Carbon Monoxide Concentration

时间窗: Morning of surgery, pre-operatively

次要结局

  • Self-reported Abstinence(Morning of surgery, pre-operatively)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

David Warner

MD

Mayo Clinic

研究点 (1)

Loading locations...

相似试验